Abstract
Intrapericardial procaine has been used by several groups to block cardiac afferent nerves to study effects of cardiogenic reflexes. In eight conscious rabbits, procaine (17-113 mg ipc; median 32) blocked cardiac efferents. Procaine (17-113 mg ipc; median 39) abolished the reflex depressor effects of the cardiac C-fiber excitant 1-phenylbiguanide (PBG), and in four of eight rabbits prevented the hypotensive phase 2 of acute central hypovolemia, which has been attributed to a signal from the heart. However, in three of the rabbits respiratory incoordination and blood gas abnormalities developed. In another study of four rabbits, procaine (165-335 mg ipc; median 235) invariably caused phrenic nerve blockade and underventilation. In three rabbits, after intrapericardial (250 mg) or subcutaneous (50 mg) procaine, plasma procaine levels rose to 9.4 and 4.8 micrograms/ml, respectively. During intravenous infusion of procaine, the PBG chemoreflex was abolished at plasma levels > 3.1 micrograms/ml, and phase 2 of acute hypovolemia at levels > or = 4.3 micrograms/ml. There is a narrow margin between a dose of intrapericardial procaine that blocks cardiac nerves and one that can produce confounding effects from phrenic nerve blockade or absorption into the bloodstream.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.